Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0055 | 0.0258 | 0.0388 |
Loa Loa (eye worm) | RNA binding protein | 0.0255 | 0.3508 | 0.3508 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.004 | 0.0017 | 0.0025 |
Schistosoma mansoni | hypothetical protein | 0.0056 | 0.0267 | 0.0403 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0655 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0124 | 0.1379 | 1 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0063 | 0.0381 | 0.0575 |
Brugia malayi | mbt repeat family protein | 0.0055 | 0.0258 | 0.0258 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0255 | 0.3508 | 0.3508 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0063 | 0.0381 | 0.1087 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0055 | 0.0258 | 0.0388 |
Loa Loa (eye worm) | hypothetical protein | 0.0266 | 0.3682 | 0.3682 |
Loa Loa (eye worm) | hypothetical protein | 0.0197 | 0.2566 | 0.2566 |
Loa Loa (eye worm) | hypothetical protein | 0.0207 | 0.2728 | 0.2728 |
Echinococcus granulosus | tar DNA binding protein | 0.0255 | 0.3508 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0124 | 0.1379 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0124 | 0.1379 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Echinococcus granulosus | smad | 0.004 | 0.0017 | 0.0047 |
Schistosoma mansoni | tar DNA-binding protein | 0.0255 | 0.3508 | 0.5287 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0055 | 0.0258 | 0.1972 |
Loa Loa (eye worm) | hypothetical protein | 0.0447 | 0.6634 | 0.6634 |
Echinococcus multilocularis | tar DNA binding protein | 0.0255 | 0.3508 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0207 | 0.2728 | 0.2728 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0063 | 0.0381 | 0.1087 |
Brugia malayi | hypothetical protein | 0.0124 | 0.1379 | 0.1379 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0381 | 0.0381 |
Schistosoma mansoni | smad1 5 8 and | 0.004 | 0.0017 | 0.0025 |
Schistosoma mansoni | smad | 0.004 | 0.0017 | 0.0025 |
Echinococcus multilocularis | smad | 0.004 | 0.0017 | 0.0047 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0059 | 0.0317 | 0.0479 |
Brugia malayi | MH2 domain containing protein | 0.004 | 0.0017 | 0.0017 |
Loa Loa (eye worm) | hypothetical protein | 0.0655 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0124 | 0.1379 | 1 |
Echinococcus multilocularis | Smad4 | 0.004 | 0.0017 | 0.0047 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0056 | 0.0267 | 0.0762 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0655 | 1 | 1 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0056 | 0.0267 | 0.0762 |
Schistosoma mansoni | hypothetical protein | 0.0207 | 0.2728 | 0.4113 |
Schistosoma mansoni | hypothetical protein | 0.0207 | 0.2728 | 0.4113 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0124 | 0.1379 | 1 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.004 | 0.0017 | 0.0047 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0079 | 0.065 | 0.065 |
Schistosoma mansoni | tar DNA-binding protein | 0.0255 | 0.3508 | 0.5287 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0079 | 0.065 | 0.1854 |
Schistosoma mansoni | alpha-glucosidase | 0.0152 | 0.1835 | 0.2765 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.004 | 0.0017 | 0.0047 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0177 | 0.2235 | 0.6371 |
Brugia malayi | MH1 domain containing protein | 0.004 | 0.0017 | 0.0017 |
Brugia malayi | MH2 domain containing protein | 0.0591 | 0.896 | 0.896 |
Mycobacterium ulcerans | putative regulatory protein | 0.0043 | 0.0069 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0335 | 0.4803 | 0.7239 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0079 | 0.065 | 0.4715 |
Brugia malayi | TAR-binding protein | 0.0255 | 0.3508 | 0.3508 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0207 | 0.2728 | 0.7779 |
Schistosoma mansoni | single-minded | 0.0059 | 0.0317 | 0.0479 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0079 | 0.065 | 0.1854 |
Echinococcus granulosus | single minded 2 | 0.0043 | 0.0069 | 0.0198 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0079 | 0.065 | 0.4715 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0177 | 0.2235 | 0.2235 |
Brugia malayi | MH2 domain containing protein | 0.004 | 0.0017 | 0.0017 |
Brugia malayi | Isocitrate dehydrogenase | 0.0079 | 0.065 | 0.065 |
Onchocerca volvulus | 0.0055 | 0.0258 | 0.1972 | |
Brugia malayi | bHLH-PAS transcription factor | 0.0043 | 0.0069 | 0.0069 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0079 | 0.065 | 0.098 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0124 | 0.1379 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0079 | 0.065 | 0.4715 |
Schistosoma mansoni | tar DNA-binding protein | 0.0255 | 0.3508 | 0.5287 |
Schistosoma mansoni | Smad4 | 0.004 | 0.0017 | 0.0025 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0217 | 0.2889 | 0.8236 |
Brugia malayi | Cytochrome P450 family protein | 0.0098 | 0.0953 | 0.0953 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0055 | 0.0258 | 0.0734 |
Schistosoma mansoni | hypothetical protein | 0.0207 | 0.2728 | 0.4113 |
Brugia malayi | MH1 domain containing protein | 0.004 | 0.0017 | 0.0017 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0079 | 0.065 | 0.4715 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0217 | 0.2889 | 0.8236 |
Schistosoma mansoni | alpha-glucosidase | 0.0152 | 0.1835 | 0.2765 |
Loa Loa (eye worm) | Smad1 | 0.004 | 0.0017 | 0.0017 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0063 | 0.0381 | 0.1087 |
Schistosoma mansoni | hypothetical protein | 0.0447 | 0.6634 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0207 | 0.2728 | 0.7779 |
Echinococcus granulosus | Smad4 | 0.004 | 0.0017 | 0.0047 |
Schistosoma mansoni | tar DNA-binding protein | 0.0255 | 0.3508 | 0.5287 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0207 | 0.2728 | 0.7779 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0255 | 0.3508 | 0.5287 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0055 | 0.0258 | 0.0734 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0079 | 0.065 | 0.1854 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0124 | 0.1379 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0079 | 0.065 | 0.1854 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.004 | 0.0017 | 0.0047 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0207 | 0.2728 | 0.2728 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0182 | 0.2318 | 0.2318 |
Brugia malayi | PAS domain containing protein | 0.0059 | 0.0317 | 0.0317 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0063 | 0.0381 | 0.0381 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0039 | 0 | 0.5 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0055 | 0.0258 | 0.0734 |
Brugia malayi | hypothetical protein | 0.0197 | 0.2566 | 0.2566 |
Schistosoma mansoni | smad1 5 8 and | 0.004 | 0.0017 | 0.0025 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0055 | 0.0258 | 0.0734 |
Loa Loa (eye worm) | MBCTL1 | 0.0063 | 0.0381 | 0.0381 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0591 | 0.896 | 0.896 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0255 | 0.3508 | 0.3508 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0043 | 0.0069 | 0.0198 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0177 | 0.2235 | 0.2235 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0055 | 0.0258 | 0.0258 |
Brugia malayi | RNA binding protein | 0.0255 | 0.3508 | 0.3508 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.1379 | 0.1379 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0258 | 0.0258 |
Onchocerca volvulus | 0.0102 | 0.1024 | 1 | |
Brugia malayi | Latrophilin receptor protein 2 | 0.0207 | 0.2728 | 0.2728 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.004 | 0.0017 | 0.0047 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0079 | 0.065 | 0.1854 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0177 | 0.2235 | 0.6371 |
Schistosoma mansoni | smad1 5 8 and | 0.004 | 0.0017 | 0.0025 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0063 | 0.0381 | 0.1087 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.004 | 0.0017 | 0.0017 |
Brugia malayi | mbt repeat family protein | 0.0055 | 0.0258 | 0.0258 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0207 | 0.2728 | 0.7779 |
Brugia malayi | isocitrate dehydrogenase | 0.0079 | 0.065 | 0.065 |
Brugia malayi | hypothetical protein | 0.008 | 0.0664 | 0.0664 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0177 | 0.2235 | 0.6371 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0079 | 0.065 | 0.4715 |
Brugia malayi | hypoxia-induced factor 1 | 0.0182 | 0.2318 | 0.2318 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0055 | 0.0258 | 0.0388 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.004 | 0.0017 | 0.0017 |
Echinococcus granulosus | GPCR family 2 | 0.0207 | 0.2728 | 0.7779 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0266 | 0.3682 | 0.3682 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0098 | 0.0953 | 0.0953 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0124 | 0.1379 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0207 | 0.2728 | 0.7779 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0079 | 0.065 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0079 | 0.065 | 0.4715 |
Schistosoma mansoni | hypothetical protein | 0.0207 | 0.2728 | 0.4113 |
Loa Loa (eye worm) | TAR-binding protein | 0.0255 | 0.3508 | 0.3508 |
Brugia malayi | Smad1 | 0.004 | 0.0017 | 0.0017 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0591 | 0.896 | 0.896 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0079 | 0.065 | 0.4715 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0079 | 0.065 | 0.1854 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0447 | 0.6634 | 0.6634 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 8 % | Induction of cell cycle arrest in human HCT116 assessed as accumulation at G2/M-phase at 10 uM after 24 hrs by FACS analysis | ChEMBL. | 18516048 |
Activity (functional) | = 17 % | Induction of cell cycle arrest in human HCT116 assessed as accumulation at S-phase at 10 uM after 24 hrs by FACS analysis | ChEMBL. | 18516048 |
Activity (functional) | = 71 % | Induction of cell cycle arrest in human HCT116 assessed as accumulation at G1-phase at 10 uM after 24 hrs by FACS analysis | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human MCF7 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human PC3 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human 786-0 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human OVCAR8 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human M14 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human K562 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human NCI-H226 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.28 uM | Cytotoxicity against human SF268 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human NCI/ADR-RES cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human DU145 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human Caki1 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human SKOV3 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human A549 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human HCT116 cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human MALME-3M cells | ChEMBL. | 18516048 |
GI50 (functional) | = 0.67 uM | Cytotoxicity against human SK-MEL-5 at 100 uM | ChEMBL. | 18516048 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.